Abstract

BackgroundWarfarin is classified as a high-alert medication for ambulatory healthcare and safe guards for high-alert medications are necessary, including the practice of mandatory patient education. The high cost of hospitalizations related to adverse events combined with the average bleeding event rate of 7–8% in spite of routine patient education, suggests the importance of new approaches to standardized health education on warfarin. We sought to evaluate the impact of a warfarin educational video using an electronic tablet on patient knowledge and to determine patients’ satisfaction with the use of an electronic tablet for educational purposes in outpatient clinics serving a low income, minority population.MethodsA warfarin educational video delivered on an electronic tablet (iPad) was delivered at two pharmacist-managed anticoagulation clinics to uninsured patients whose annual income is equal or less than two hundred percent below the poverty level were offered. Patients (n = 18) completed a pre-video and post-video knowledge test on warfarin before and after viewing the warfarin educational video on an electronic tablet and a follow-up test to measure the retention of knowledge and a patient satisfaction survey at 60 days. The primary outcome was change in knowledge test scores. Other outcome measures included adherence rates, adverse events, time in therapeutic INR range, and patient-reported satisfaction scores.ResultsThe majority of patients were uninsured men taking warfarin for atrial fibrillation (n = 5). The median scores at post-video knowledge test and follow-up knowledge test were significantly higher than that for the pre-knowledge test (12 (11–12) vs. 10(8–11), p < 0.001). The study group had a ‘time in therapeutic INR’ range of 56.3%, a rate of adverse events of 24.5%, and a self-reported adherence rate to warfarin of 94.1%. The majority of patients also had positive responses to the patient satisfaction survey.ConclusionsPatient education delivered via iPad to facilitate knowledge of medication can serve as a useful tool for educating patients about warfarin and warfarin therapy. Use of an electronic medium may be a unique way to provide standard medication education to patients.Trial registrationThe study was retrospectively registered with: NCT03650777; 9/18/18.

Highlights

  • Warfarin is classified as a high-alert medication for ambulatory healthcare and safe guards for highalert medications are necessary, including the practice of mandatory patient education

  • Warfarin safety and patient education According to the Institute for Safe Medication Practices (ISMP), warfarin is classified as a high-alert medication for ambulatory healthcare [1]

  • This is mainly due to its narrow therapeutic index, which requires close follow up in clinics to test the International Normalized Ratio (INR), used to determine if the warfarin dose is within therapeutic range

Read more

Summary

Introduction

Warfarin is classified as a high-alert medication for ambulatory healthcare and safe guards for highalert medications are necessary, including the practice of mandatory patient education. Warfarin safety and patient education According to the Institute for Safe Medication Practices (ISMP), warfarin is classified as a high-alert medication for ambulatory healthcare [1]. This is mainly due to its narrow therapeutic index, which requires close follow up in clinics to test the International Normalized Ratio (INR), used to determine if the warfarin dose is within therapeutic range. Shrestha et al reported 94.1% of enrolled patients on warfarin therapy receiving traditional counseling methods failed to achieve a passing score using the AKA questionnaire [6]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.